Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 4,042 | 6,954 | 3,582 | 1,224 | 0 |
| Cost of Goods | 165 | 128 | 268 | 95 | N/A |
| Gross Profit | 3,877 | 6,826 | 3,314 | 1,129 | N/A |
| Operating Expenses | 37,293 | 41,077 | 25,490 | 18,685 | 25,661 |
| Operating Income | -33,251 | -34,123 | -21,908 | -17,461 | -25,661 |
| Interest Expense | 465 | 546 | 341 | 10 | 2 |
| Other Income | 5,344 | -3,145 | -6 | -2 | 2 |
| Pre-tax Income | -28,372 | -37,814 | -22,255 | -17,473 | -25,661 |
| Income Tax | N/A | -2,325 | -7,252 | -7,376 | -3,281 |
| Net Income Continuous | -28,372 | -35,489 | -15,003 | -10,097 | -22,380 |
| Net Income | $-28,372 | $-35,489 | $-15,003 | $-10,097 | $-22,380 |
| EPS Basic Total Ops | -0.56 | -0.83 | -0.42 | -0.33 | -2.90 |
| EPS Basic Continuous Ops | -0.56 | -0.83 | -0.42 | -0.33 | -2.90 |
| EPS Diluted Total Ops | -0.56 | -0.83 | -0.42 | -0.33 | -2.90 |
| EPS Diluted Continuous Ops | -0.56 | -0.83 | -0.42 | -0.33 | -2.90 |
| EPS Diluted Before Non-Recurring Items | -0.56 | -0.76 | -0.63 | -0.33 | -2.90 |
| EBITDA(a) | $-29,455 | $-30,261 | $-18,573 | $-12,057 | $-24,630 |